A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer

I6A-MC-CBBD -

The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY3023414 in combination with enzalutamide in men with prostate cancer.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Prostate Cancer
What the trial is testing?
Samotolisib, Enzalutamide
Could I receive a Placebo?
Yes
Enrollment Goal
142
Trial Dates
Apr 29, 2015 - Apr 16, 2020
How long will I be in the trial?
Your participation could last up to 56 days or longer if you are tolerating the study drug and your study doctor thinks your condition is stable or improving.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.